In this context, our review aims to provide an updated overview of ANXA1 roles in CRC progression, with a specific focus on LARC, in addition to its potential role as a predictive and prognostic biomarker in the settings of nCRT. This evidence concerns the gene ANXA1 and colorectal carcinoma.